Homology modeling of α-glucosidase and its interactions with andrograpolide derivatives

Letters in Drug Design and Discovery

Volumn 8, Issue 5, 2011, Pages 440-451

  Xu, Jun ^a   Lu, Yijing ^a   Shen, Weizai ^c   Luo, Haibin ^b   Huang, Sichao ^a   Bao, Jiaolin ^a   Cai, Shaohui ^a   Wang, Yuqiang ^a  

^a JINAN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

glucosidase; Andrographolide; Dock; Homology modeling

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPOLIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DRUG STRUCTURE; ENZYME ACTIVE SITE; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY;

EID: 79955783954     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018011795514203     Document Type: Article

References (37)

1. Zhang, C. Y.; Tan, B. K. Effects of 14-deoxyandrographolide and 14-deoxy-11, 12-didehydroandrographolide on nitric oxide production in cultured human endothelial cells. Phytother. Res., 1999, 13(2), 157-159. (Pubitemid 29129452)
2. Sabu, K. K.; Padmesh, P.; Seeni, S. J. Intraspecific variation in active principle content and isozymes of Andrographis paniculata (kalmegh): a traditional hepatoprotective medicinal herb of India. Med. Aromatic. Plant. Sci., 2001, 23(4), 637-647.
3. Bernacki, R. J.; Niedbala, M. J.; Korytnyk, W. Glycosidases in cancer and invasion. Cancer Metastasis Rev., 1985, 4(1), 81-101.
4. Pili, R.; Chang, J.; Partis, R. A.; Mueller, R. A.; Chrest, F. J.; Passaniti, A. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res., 1995, 55(13), 2920-2926.
5. Humphries, M. J.; Matsumoto, K.; White, S. L.; Olden, K. Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res., 1986, 46(10), 5215-5222. (Pubitemid 16008292)
6. Papandreou, M. J.; Barbouche, R.; Guieu, R.; Kieny, M. P.; Fenouillet, E. The alpha-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoproteinmediated membrane fusion at the CXCR4 binding step. Mol. Pharmacol., 2002, 61(1), 186-193. (Pubitemid 34049526)
7. Ouzounov, S.; Mehta, A.; Dwek, R. A.; Block, T. M.; Jordan, R. The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral. Res., 2002, 55(3), 425-435. (Pubitemid 35223098)
8. Schmidt, D. D.; Frommer, W.; Junge, B.; Muller, L.; Wingender, W.; Truschei, E.; Schafer, D. Alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin. Naturwissenschaften, 1977, 64(10), 535-536. (Pubitemid 8197893)
9. Kameda, Y.; Asano, N.; Yoshikawa, M.; Takeucki, M.; Yamaguchi, T.; Matsui, K.; Horii, S.; Fukase, H. J. Valiolamine, a new al pha-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. Antibiot, 1984, 37(11), 1301-1307. (Pubitemid 15220687)
10. Robinson, K. M.; Begovic, M. E.; Rhinehart, B. L.; Heineke, E. W.; Ducep, J. B.; Kastner, P. R.; Marshall, F. N.; Danzin, C. New potent alpha-glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes, 1991, 40(7), 825-830.
11. Fujisawa, T.; Ikegami, H.; Inoue, K.; Kawabata, Y.; Ogihara, T. Effect of two alpha-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism, 2005, 54(3), 387-390. (Pubitemid 40250100)
12. Van den Broek, L. A. G. M.; Kat-Van Den Nieuwenhof, M. W.; Butters, T. D.; Van Boeckel, C. A. Synthesis of alpha-glucosidase I inhibitors showing antiviral (HIV-1) and immunosuppressive activity. J. Pharm. Pharmacol., 1996, 48(2), 172-178. (Pubitemid 26129086)
13. Dai, G. F.; Xu, H. W.; Wang, J. F.; Liu, F. W.; Liu, H. M. Studies on the novel alpha-glucosidase inhibitory activity and structureactivity relationships for andrographolide analogues. Bioorg. Med. Chem., 2006, 16(10), 2710-2713.
14. Xu, H. W.; Dai, G. F.; Liu, G. Z.; Wang. J. F.; Liu, H. M. Synthesis of andrographolide derivatives: A new family of alpha-glucosidase inhibitors. Bioorg. Med. Chem., 2007, 15(12), 4247-4255.
15. Truscheit, E.; Frommer, W.; Junge, B.; Muller, L.; Schmidt, D. D.; Wingender, W. Chemistry and biochemistry of microbial alphaglucosidase inhibitors. Angew. Chem., 1981, 93(9), 738-755.
16. Madariaga, H.; Lee, P. C.; Heitlinger, L. A.; Lenenthal, M. Effects of graded alpha-glucosidase inhibition on sugar absorption in vivo. Dig. Dis. Sci., 1988, 33(8), 1020-1024.
17. Lee, D.-S.; Lee, S.-H. Genistein, a soy isoflavone, is a potent alpha- glucosidase inhibitor. FEBS Lett., 2001, 501(1), 84-86. (Pubitemid 33712492)
18. McCulloch, D. K.; Kurtz, A. B.; Tattersall, R. B. A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care, 1983, 6(5), 483-487. (Pubitemid 13005558)
19. Sou, S.; Takahashi, H.; Yamasaki, R.; Kagechika, H.; Endo, Y.; Hashimoto, Y. Alpha-glucosidase inhibitors with a 4,5,6,7-tetrachlorophthalimide skeleton pendanted with a cycloalkyl or dicarba-closo-dodecaborane group. Chem. Pharm. Bull., 2001, 49(6), 791-793. (Pubitemid 32587136)
20. Node, K. Alpha-glucosidase inhibitors: new therapeutic agents for chronic heart failure. Hypertens. Res., 2006, 29(10), 741-742. (Pubitemid 44842806)
21. Brenk, R.; Naerum, L.; Grädler, U.; Gerber, H. D.; Garcia, G. A.; Reuter, K.; Stubbs, M. T.; Klebe, G. Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on new unexpected binding model detected by crystal structure analysis. J. Med. Chem., 2003, 46, 1133-1143. (Pubitemid 36428219)
22. Costi, M. P.; Tondi, D.; Rinald, M.; Barlocco, D.; Pecorari, P.; Soragni, F.; Venturell, R.; Stroud, R. M. Structure-based studies on specifies-specific inhibition of thymidylate synthase. BBA-Mol. Basis. Dis., 2002, 1587, 206-214. (Pubitemid 34655789)
23. Grünberg, S.; Stubbs, M.; Klebe, G. Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation. J. Med. Chem., 2002, 45, 3588-3602. (Pubitemid 34863232)
24. Ilon, M.; Furugori, T.; Mori, T.; Moriyama, S.; Fukuzawa, A.; Shibano, T. Rational design of new lead compounds: structures for selective βARKl inhibitors. J. Med. Chem., 2002, 45, 2150-2159. (Pubitemid 34525795)
25. Power, R. A.; Morandi, F.; Shoichet, B. K. Structure-based discovery of a novel nonvalent inhibitor of AmpC -lactamase. Structure, 2002, 10, 1013-1023. (Pubitemid 34786743)
26. Rastelli, G.; Ferrari, A. M.; Costantino, L.; Gamberini, M. C. Discovery of new inhibitors of aldose reductase from molecular modeling and database searching. Bioorgan. Med. Chem., 2002, 10, 1437-1450. (Pubitemid 34214707)
27. SiteID Manual. Tripos, 2006.
28. Jain, A. N. Surflex-Dock 2.1: Robust performance from ligand energetic modeling, ring flexibility, and knowledge-based search. J. Comput-Aided Mol. Des., 2007, 21(5), 281-306. (Pubitemid 46630055)
29. Shi, J.; Blundell, T. L.; Mizuguchi, K. FUGUE: Sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol., 2001, 310, 243-257. (Pubitemid 32619966)
30. Mizuguchi, K.; Deane, C.; Blundell, T.; Overington, J. HOMSTRAD: A database of protein structure alignments for homologous families. Protein Sci., 1998, 7, 2469-2471. (Pubitemid 28506965)
31. Michael, A. D.; Matthias, K.; David, S. B. Comparison of composer and ORCHESTRAR. Protein-Struct. Funct. Bioinform., 2008, 72(4), 1243-1258.
32. Shun Xu. Ph.D. Dissertation, Dept. Org. Chem., Univ. ZhengZhou, China. 2006.
33. Jun, X.; Sichao, H.; Haibin, L. QSAR studies on andrographolide derivatives as a-glucosidase inhibitors. Int. J. Mol. Sci., 2010, 11(3), 880-895.
34. Wang, Y.T.; Chan, C.H.; Su, Z.Y. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A (H1N1) influenza neuraminidase. Biophys. Chem., 2010, 142(1-2), 74-80.
35. Durdagi, S.; Papadopoulos, M.G.; Zoumpoulakis, P.G. A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis. Mol. Divers., 2010, 14(2), 257-276.
36. http://www.rcsb.org/pdb/explore/explore.do?structureId=1UOK.
37. Watanabe, K.; Hata, Y.; Kizaki, H. The refined crystal structure of Bacillus cereus oligo-1, 6-glucosidase at 2.0 Ǻ resolution: structural characterization of proline-substitution sites for protein thermostabilization. J. Mol. Biol., 1997, 269(1), 142-153. (Pubitemid 27243627)